There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. After-hours trades for Community Health Systems Inc. (CYH) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$0.16, or -5.88%, to $2.56. Volume reached 22,644 shares, with price reaching a high of $2.56 and a low of $2.56. The stock was recently discussed on Yahoo Finance as it revealed that Community Health Systems, Inc. Announces Second Quarter Ended June 30, 2022 Results.
As a NYSE listed company, CYH falls under the Healthcare sector while operating within the Medical Care Facilities industry segment. At the end of the last regular session, the stock closed at $2.56 and fluctuated between $2.7000 as its day high and $2.5400 as its day low. The current market capitalization of Community Health Systems Inc. is $350.82M. A total of 2.44 million shares were traded on the day, compared to an average of 3.14M shares.
Aside from predicting where a stock will go, investors also consider insider trades as an indicator of the stock’s future direction. During the recent three months, CYH has seen 3 BUY and 0 SELL insider trades, representing the acquisition of 1,037,957 and the disposition of 0 shares. Over the last 12 months, there were 37 BUYs and 11 SELLs from insiders. Insiders purchased 2,415,018 shares during that period but sold 407,195.
In the most recent transaction, SMITH WAYNE T bought 800,000 shares of CYH for 2.94 per share on Aug 02. After the transaction, the Executive Chairman now owns 4,059,196 company shares. In a previous transaction on Aug 01, SMITH WAYNE T bought 200,000 shares at 3.00 per share. CYH shares that Executive Chairman owns now total 3,259,196.
Among the insiders who bought shares, Ely James S. III acquired of 10,000 shares on Jun 02 at a per-share price of $5.00. This resulted in the Director holding 301,299 shares of CYH after the transaction. In another insider transaction, Ely James S. III bought 30,000 shares at $5.09 per share on Jun 01. Company shares held by the Director now total 291,299.
Investors prefer companies that pay dividends because dividends generate immediate cash flow and indicate a positive outlook. CYH’s most recent ex-dividend date was 12/13/2012 when it declared a $0.25 quarterly dividend that was paid in cash on 12/28/2012.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. According to analysts who have offered 12-month price targets for CYH in the last 3 months, the mean price target is $5.52 with high estimates of $13.75 and low estimates of $3.00. In terms of 52-week highs and lows, CYH has a high of $15.29 and a low of $2.56.
As of this writing, CYH has an earnings estimate of $0.05 per share for the current quarter. EPS was calculated based on a consensus of 5 estimates, with a high estimate of $0.23 per share and a lower estimate of $-0.09.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects.
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 12 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CYH is Hold with a score of 3.67. A total of 4 analysts rated the stock as Buy while 0 rated it as Overweight while 8 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.